Navigation Links
Exposure to worm infection in the womb may protect against eczema, study suggests
Date:1/28/2011

Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed that treating a pregnant woman for worm infections increased her child's chances of developing the allergic skin disease.

Published this week in the journal Pediatric Allergy and Immunology, the research supports the so-called 'hygiene hypothesis', which proposes that exposure to infections in early childhood can modify the immune system and protect the child from allergies later in life.

The World Health Organisation estimates that one in five of the world's population suffers from allergic diseases such as asthma and eczema, but this epidemic is no longer restricted to developed countries: more than four out of five deaths due to asthma occur in low and lower-middle income countries. The declining incidence and prevalence of infectious diseases including chronic infection by worms known as helminths is widely considered to be an important contributor contributing to this increase.

Helminth infection can cause symptoms ranging from mild anaemia through to stomach pain and vomiting, depending on how intense the infection is, but very often people have no symptoms at all. The parasitic worms tend to enter the body through contaminated food or water, mosquito bites or through walking in bare feet on contaminated soil.

A preliminary study carried out at the MRC/UVRI Uganda Research Unit on AIDS in Entebbe, Uganda in 2005 showed a reduced risk of eczema among infants whose mothers had worms and suggested an increased incidence among infants of mothers who received albendazole a commonly used drug to treat worm infection during pregnancy compared to infants whose mothers received a placebo.

In a follow-up study, researchers carried out a randomised, double-blind trial on 2,507 pregnant women in Uganda, comparing those treated with either albendazole or a second drug, praziquantel, against those administered a placebo, and looking at how this affected their offspring's risk of developing eczema.

Harriet Mpairwe, first author of the new study, says: "Worm infections can adversely affect a person's health, but the evidence also suggests that exposure to infection early in a child's life can have a beneficial effect in terms of modifying its immune system and protecting against allergies. We wanted to examine in a large cohort what effect de-worming women during pregnancy has on their offspring."

The researchers showed for the first time that treatment of pregnant women with albendazole appeared to almost double the risk of eczema in their offspring (an increase by a factor of 1.8) and that treatment with praziquantel more than doubled (an increase by a factor of 2.6) the risk of eczema among infants of mothers infected by the Schistosoma mansoni worm (a parasite which causes the disease schistosomiasis).

The findings support the hypothesis that maternal worms during pregnancy, neonatal life and early breastfeeding, may protect against allergy in infancy and that treatment of these worms during pregnancy increases the risk of allergy.

Professor Alison Elliott from the London School of Hygiene and Tropical Medicine, senior author of the study, says: "Our study suggests that routine de-worming during pregnancy, in settings where most worm infections are mild, may not be beneficial for the children and may actually cause problems with allergy. However, before we recommend changes to treatment policy, we need to do more work to confirm these findings and better understand what is happening.

"The findings certainly support the so-called 'hygiene hypothesis'. What will be important for the eczema story will be to see whether there are long term effects on allergy, especially asthma, at school age. Our next step is to investigate this further."


'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related biology news :

1. Study: Bird diversity lessens human exposure to West Nile Virus
2. Birth control has long-term effect on hormone exposure
3. Major source of radon exposure overlooked at former Ohio uranium-processing plant
4. Household exposure to toxic chemicals lurks unrecognized, researchers find
5. Study reveals effects of unconscious exposure to advertisements
6. Benefits of breastfeeding outweigh risk of infant exposure to environmental chemicals in breastmilk
7. Novel technique changes lymph node biopsy, reduces radiaiton exposure
8. Novel technique changes lymph node biopsy, reduces radiation exposure
9. Swimmers at public beaches show increased risk of exposure to contagious staph bacteria
10. How increased UV exposure impacts plants
11. Exposure to insecticide may play role in obesity epidemic among some women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:6/20/2017)... 20, 2017  Kibow Biotech Inc., a pioneer in ... issuance of a new patent covering a unique method ... U.S. Patent and Trademark Office on May 23 rd ... Buzz of Bio award in 2014 in ... non-drug approaches to chronic disease. Renadylâ„¢, the first and ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Do More with ... transition from being a trusted supplier in the weighing industry, to extending its expertise ... ELISA essays, enzyme reactions, immunoassays, hybridizations and more, allowing for its customers ...
(Date:6/19/2017)... ... June 19, 2017 , ... As Vice President, ... products including training, implementation, support, and client process and SOP development. , Mr. ... previously held leadership roles for service providers and top-tier pharmaceuticals, and as an ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... Tunnell ... for over 50 years. One of the biggest challenges faced by life sciences, biotech ... regulatory affairs services team is Kati Abraham , who is well known in ...
Breaking Biology Technology: